Home Biosimilar Antibodies Proteases DPP inhibitor Begelomab (Anti-DPP4 / CD26)
For research use only. Not for use in humans.

Begelomab (Anti-DPP4 / CD26)

Synonyms: SAND-26

Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.

Begelomab (Anti-DPP4 / CD26)

Quality Control

Batch: A251701 Purity: 99% Protein concentration: 12.08mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation DPP-2 DPP-4 DPP-8 DPP-9 DPP-1 Others
Teneligliptin Hydrobromide Hydrate 0
Bestatin hydrochloride 0 Aminopeptidase N
Gemigliptin 0
Talabostat (PT-100) 8 PEP
Anagliptin 0
Trelagliptin succinate 0
Omarigliptin (MK-3102) 3
Teneligliptin hydrobromide 0
Trelagliptin 0
Brensocatib 1
Puromycin aminonucleoside 6 cytosol alanyl aminopeptidase
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.

Product Details

CAS No. 1403744-56-8
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.